EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateAntonis Fanouriakis, Dimitrios T. Boumpas, Gabriella Moroni et al.|Annals of the Rheumatic Diseases|2023Cited by 913
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Murray B. Urowitz, Alexandre E. Voskuyl et al.|Annals of the Rheumatic Diseases|2016Cited by 355
2021 DORIS definition of remission in SLE: final recommendations from an international task forceRonald van Vollenhoven, Y K Onno Teng, George Βertsias et al.|Lupus Science & Medicine|2021Cited by 340
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodiesLaurent Arnaud, Zahir Amoura, Alexis Mathian et al.|Autoimmunity Reviews|2014Cited by 146
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndromeC. Belizna, Laurent Loufrani, Francesca Pregnolato et al.|Autoimmunity Reviews|2018Cited by 76